세계의 간질 원격 의료 시장 : 규모, 점유율, 동향 분석 보고서 - 환자별, 최종 용도별, 컴포넌트별, 지역별 전망과 예측(2024-2031년)

Global Tele-epilepsy Market Size, Share & Trends Analysis Report By Patient (Adult and Pediatric), By End Use (Healthcare Consumers, Hospitals Providers, and Payers), By Component, By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 5,152,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,182,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,655,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

간질 원격 의료 시장 규모는 예측 기간 동안 15.5%의 연평균 복합 성장률(CAGR)로 성장하고 2031년까지 13억 달러에 달할 것으로 예상됩니다.

그러나 건강 관리 자원이 이미 제한된 저소득 지역에서는 간질 원격 의료 인프라와 관련된 비용이 엄청나게 높아질 수 있습니다. 특히 투자 수익이 불확실하거나 정부 지원이 부족한 경우 고도 디지털 도구에 투자하는 것보다 기본적인 의료 요구를 우선 할 수 있습니다. 그 결과, 시장의 잠재적인 범위와 성장이 제한 될 수 있습니다.

환자 전망

환자를 기반으로 시장은 성인과 소아로 나뉘어져 있습니다. 성인 부문은 2023년 시장에서 55%의 수익 점유율을 차지했습니다. 만성 질환 관리를 위한 원격 의료 채용 증가에 의해 추진되고 있습니다. 간질을 앓고있는 많은 성인은 원격 의료의 유연성과 편리성의 혜택을 받고 있으며 전문의와 상담하거나 정기적인 모니터링을 받거나 자주 직접 방문 없이 상태를 관리할 수 있습니다.

최종 용도 전망

최종 용도에 따라 시장은 건강 관리 소비자, 병원 및 지불자로 분류됩니다. 확대하고 더 넓은 환자 기반에 전문적인 간질 관리를 제공하기 위해 간질 원격 의료 플랫폼을 채용함으로써 추진되고 있습니다. 간질 원격 의료를 서비스에 통합하는 경향이 높아지고 있습니다.

구성 요소 전망

컴포넌트별로 볼 때 시장은 소프트웨어, 하드웨어, 서비스로 나뉘어져 있습니다. 같은 중요한 구성 요소로 인해 간질 사람들의 원격지에서 정확한 평가와 지속적인 관리가 가능합니다. 성이 있고 사용하기 쉬운 하드웨어 수요가 급증하고, 가장 수익을 창출하는 부문이 되고 있습니다.

지역 전망

지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에 걸쳐 분석되고 있습니다. 원격의료서비스에 대한 정부의 지원정 책과 광범위한 보험 적용으로 환자와 의료 제공업체 모두에서 도입이 촉진되고 있습니다. 수익 점유율을 획득하는 원동력이되고 있습니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

• 주요 하이라이트

제3장 시장 개요

• 소개
  • 개요
    • 시장구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 과제
• Porter's Five Forces 분석

제4장 세계 시장 : 환자별

• 세계의 성인용 시장 :지역별
• 세계의 소아용 시장 :지역별

제5장 세계 시장 : 최종 용도별

• 세계의 헬스케어 소비자 시장 :지역별
• 세계의 병원 시장 :지역별
• 세계의 지불자 시장 : 지역별

제6장 세계 시장 : 컴포넌트별

• 세계의 소프트웨어 시장 :지역별
• 세계의 하드웨어 시장 :지역별
• 세계의 서비스 시장 :지역별

제7장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카, 중동 및 아프리카
  • 라틴아메리카, 중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카
    • 나이지리아
    • 기타 라틴아메리카, 중동 및 아프리카

제8장 기업 프로파일

• Shimmer Research Ltd
• EMOTIV, Inc
• CortiCare, Inc
• SEVARO
• Tele Specialists
• Real Time Tele-Epilepsy Consultants
• ScienceSoft USA Corporation
• Zeto, Inc
• TeleEEG
• Epitel, Inc

제9장 간질 원격 의료 시장에서의 성공 필수 조건

JHS

영문 목차

영문목차

The Global Tele-epilepsy Market size is expected to reach $1.3 billion by 2031, rising at a market growth of 15.5% CAGR during the forecast period.

Governments and healthcare organizations in Europe actively support telemedicine initiatives, with robust reimbursement frameworks encouraging tele-epilepsy services. Moreover, Europe's high healthcare standards and emphasis on innovative treatment solutions make tele-epilepsy an appealing option, particularly for patients seeking specialized care without the burden of frequent travel. This support for accessible, advanced healthcare has contributed to Europe's substantial revenue share in the market. Hence, the Europe segment acquired 32% revenue share in the market in 2023. Europe's tele-epilepsy market has expanded significantly due to the region's proactive healthcare policies, technological advancements, and increasing public awareness of epilepsy management options.

The treatment process for epilepsy patients is significantly streamlined by digital health tools, such as cloud-based platforms and smartphone applications. These tools offer features such as seizure tracking, medication reminders, and educational resources, encouraging better adherence to treatment plans and enabling patients to be proactive in managing their condition. This data can be accessed remotely by providers, enabling them to make informed decisions without the need for frequent hospital visits. Thus, these advancements are propelling the growth of the market. Additionally, for many underserved populations, tele-epilepsy also enhances continuity of care. Patients can engage in regular follow-ups and maintain consistent communication with their specialists, which is critical in managing a chronic condition like epilepsy. This continuity allows specialists to monitor treatment efficacy and make adjustments as needed based on real-time data, which can be particularly valuable in optimizing outcomes and preventing complications. Therefore, the ability of tele-epilepsy to reach underserved populations and provide accessible, specialized care is driving the demand for tele-epilepsy.

However, for low-income regions, where healthcare resources are already limited, the costs associated with tele-epilepsy infrastructure can be prohibitive. Many healthcare providers in these areas operate on tight budgets. They may prioritize basic medical needs over investing in advanced digital tools, particularly if there is uncertainty about the return on investment or a lack of government support. Hence, without external support, such as subsidies or grants, these providers may be unable to adopt tele-epilepsy platforms, thus restricting the potential reach and growth of the market.

Patient Outlook

Based on patient, the market is bifurcated into adult and pediatric. The adult segment garnered 55% revenue share in the market in 2023. The adult segment in the market is primarily driven by the high prevalence of epilepsy among adults and the increasing adoption of telemedicine for managing chronic conditions. Many adults with epilepsy benefit from the flexibility and convenience of remote care, allowing them to consult specialists, receive regular monitoring and manage their condition without frequent in-person visits.

End Use Outlook

On the basis of end use, the market is classified into healthcare consumers, hospital providers, and payers. The hospital providers segment recorded 36% revenue share in the market in 2023. The hospital providers segment is driven by hospitals' adoption of tele-epilepsy platforms to expand their services and provide specialized epilepsy care to a broader patient base. Hospitals are increasingly integrating tele-epilepsy into their offerings to reduce the burden on emergency departments, manage epilepsy cases more efficiently, and attract patients who seek reputable facilities with remote care options.

Component Outlook

By component, the market is divided into software, hardware, and services. The hardware segment witnessed 40% revenue share in the market in 2023. Essential components such as cameras, microphones, EEG devices, and other monitoring hardware enable accurate assessments and ongoing management of epilepsy patients from a distance. As tele-epilepsy becomes a preferred solution for many, especially in rural or underserved areas, the demand for durable, user-friendly hardware has surged, making it the highest revenue-generating segment.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 36% revenue share in the market in 2023. Supportive government policies and widespread insurance coverage for telemedicine services, including epilepsy care, have driven adoption among patients and providers alike. The presence of major healthcare providers and tech companies developing advanced tele-epilepsy platforms has also propelled this region to capture the highest revenue share.

List of Key Companies Profiled

• Shimmer Research Ltd.
• Emotiv Inc.
• CortiCare, Inc.
• SEVARO
• Tele Specialists
• Real Time Tele-Epilepsy Consultants
• ScienceSoft USA Corporation
• Zeto, Inc.
• TeleEEG
• Epitel, Inc.

Global Tele-epilepsy Market Report Segmentation

By Patient

• Adult
• Pediatric

By End Use

• Healthcare Consumers
• Hospitals Providers
• Payers

By Component

• Software
• Hardware
• Services

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Tele-epilepsy Market, by Patient
  • 1.4.2 Global Tele-epilepsy Market, by End Use
  • 1.4.3 Global Tele-epilepsy Market, by Component
  • 1.4.4 Global Tele-epilepsy Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Tele-epilepsy Market by Patient

• 4.1 Global Adult Market by Region
• 4.2 Global Pediatric Market by Region

Chapter 5. Global Tele-epilepsy Market by End Use

• 5.1 Global Healthcare Consumers Market by Region
• 5.2 Global Hospitals Providers Market by Region
• 5.3 Global Payers Market by Region

Chapter 6. Global Tele-epilepsy Market by Component

• 6.1 Global Software Market by Region
• 6.2 Global Hardware Market by Region
• 6.3 Global Services Market by Region

Chapter 7. Global Tele-epilepsy Market by Region

• 7.1 North America Tele-epilepsy Market
  • 7.1.1 North America Tele-epilepsy Market by Patient
    • 7.1.1.1 North America Adult Market by Country
    • 7.1.1.2 North America Pediatric Market by Country
  • 7.1.2 North America Tele-epilepsy Market by End Use
    • 7.1.2.1 North America Healthcare Consumers Market by Country
    • 7.1.2.2 North America Hospitals Providers Market by Country
    • 7.1.2.3 North America Payers Market by Country
  • 7.1.3 North America Tele-epilepsy Market by Component
    • 7.1.3.1 North America Software Market by Country
    • 7.1.3.2 North America Hardware Market by Country
    • 7.1.3.3 North America Services Market by Country
  • 7.1.4 North America Tele-epilepsy Market by Country
    • 7.1.4.1 US Tele-epilepsy Market
      • 7.1.4.1.1 US Tele-epilepsy Market by Patient
      • 7.1.4.1.2 US Tele-epilepsy Market by End Use
      • 7.1.4.1.3 US Tele-epilepsy Market by Component
    • 7.1.4.2 Canada Tele-epilepsy Market
      • 7.1.4.2.1 Canada Tele-epilepsy Market by Patient
      • 7.1.4.2.2 Canada Tele-epilepsy Market by End Use
      • 7.1.4.2.3 Canada Tele-epilepsy Market by Component
    • 7.1.4.3 Mexico Tele-epilepsy Market
      • 7.1.4.3.1 Mexico Tele-epilepsy Market by Patient
      • 7.1.4.3.2 Mexico Tele-epilepsy Market by End Use
      • 7.1.4.3.3 Mexico Tele-epilepsy Market by Component
    • 7.1.4.4 Rest of North America Tele-epilepsy Market
      • 7.1.4.4.1 Rest of North America Tele-epilepsy Market by Patient
      • 7.1.4.4.2 Rest of North America Tele-epilepsy Market by End Use
      • 7.1.4.4.3 Rest of North America Tele-epilepsy Market by Component
• 7.2 Europe Tele-epilepsy Market
  • 7.2.1 Europe Tele-epilepsy Market by Patient
    • 7.2.1.1 Europe Adult Market by Country
    • 7.2.1.2 Europe Pediatric Market by Country
  • 7.2.2 Europe Tele-epilepsy Market by End Use
    • 7.2.2.1 Europe Healthcare Consumers Market by Country
    • 7.2.2.2 Europe Hospitals Providers Market by Country
    • 7.2.2.3 Europe Payers Market by Country
  • 7.2.3 Europe Tele-epilepsy Market by Component
    • 7.2.3.1 Europe Software Market by Country
    • 7.2.3.2 Europe Hardware Market by Country
    • 7.2.3.3 Europe Services Market by Country
  • 7.2.4 Europe Tele-epilepsy Market by Country
    • 7.2.4.1 Germany Tele-epilepsy Market
      • 7.2.4.1.1 Germany Tele-epilepsy Market by Patient
      • 7.2.4.1.2 Germany Tele-epilepsy Market by End Use
      • 7.2.4.1.3 Germany Tele-epilepsy Market by Component
    • 7.2.4.2 UK Tele-epilepsy Market
      • 7.2.4.2.1 UK Tele-epilepsy Market by Patient
      • 7.2.4.2.2 UK Tele-epilepsy Market by End Use
      • 7.2.4.2.3 UK Tele-epilepsy Market by Component
    • 7.2.4.3 France Tele-epilepsy Market
      • 7.2.4.3.1 France Tele-epilepsy Market by Patient
      • 7.2.4.3.2 France Tele-epilepsy Market by End Use
      • 7.2.4.3.3 France Tele-epilepsy Market by Component
    • 7.2.4.4 Russia Tele-epilepsy Market
      • 7.2.4.4.1 Russia Tele-epilepsy Market by Patient
      • 7.2.4.4.2 Russia Tele-epilepsy Market by End Use
      • 7.2.4.4.3 Russia Tele-epilepsy Market by Component
    • 7.2.4.5 Spain Tele-epilepsy Market
      • 7.2.4.5.1 Spain Tele-epilepsy Market by Patient
      • 7.2.4.5.2 Spain Tele-epilepsy Market by End Use
      • 7.2.4.5.3 Spain Tele-epilepsy Market by Component
    • 7.2.4.6 Italy Tele-epilepsy Market
      • 7.2.4.6.1 Italy Tele-epilepsy Market by Patient
      • 7.2.4.6.2 Italy Tele-epilepsy Market by End Use
      • 7.2.4.6.3 Italy Tele-epilepsy Market by Component
    • 7.2.4.7 Rest of Europe Tele-epilepsy Market
      • 7.2.4.7.1 Rest of Europe Tele-epilepsy Market by Patient
      • 7.2.4.7.2 Rest of Europe Tele-epilepsy Market by End Use
      • 7.2.4.7.3 Rest of Europe Tele-epilepsy Market by Component
• 7.3 Asia Pacific Tele-epilepsy Market
  • 7.3.1 Asia Pacific Tele-epilepsy Market by Patient
    • 7.3.1.1 Asia Pacific Adult Market by Country
    • 7.3.1.2 Asia Pacific Pediatric Market by Country
  • 7.3.2 Asia Pacific Tele-epilepsy Market by End Use
    • 7.3.2.1 Asia Pacific Healthcare Consumers Market by Country
    • 7.3.2.2 Asia Pacific Hospitals Providers Market by Country
    • 7.3.2.3 Asia Pacific Payers Market by Country
  • 7.3.3 Asia Pacific Tele-epilepsy Market by Component
    • 7.3.3.1 Asia Pacific Software Market by Country
    • 7.3.3.2 Asia Pacific Hardware Market by Country
    • 7.3.3.3 Asia Pacific Services Market by Country
  • 7.3.4 Asia Pacific Tele-epilepsy Market by Country
    • 7.3.4.1 China Tele-epilepsy Market
      • 7.3.4.1.1 China Tele-epilepsy Market by Patient
      • 7.3.4.1.2 China Tele-epilepsy Market by End Use
      • 7.3.4.1.3 China Tele-epilepsy Market by Component
    • 7.3.4.2 Japan Tele-epilepsy Market
      • 7.3.4.2.1 Japan Tele-epilepsy Market by Patient
      • 7.3.4.2.2 Japan Tele-epilepsy Market by End Use
      • 7.3.4.2.3 Japan Tele-epilepsy Market by Component
    • 7.3.4.3 India Tele-epilepsy Market
      • 7.3.4.3.1 India Tele-epilepsy Market by Patient
      • 7.3.4.3.2 India Tele-epilepsy Market by End Use
      • 7.3.4.3.3 India Tele-epilepsy Market by Component
    • 7.3.4.4 South Korea Tele-epilepsy Market
      • 7.3.4.4.1 South Korea Tele-epilepsy Market by Patient
      • 7.3.4.4.2 South Korea Tele-epilepsy Market by End Use
      • 7.3.4.4.3 South Korea Tele-epilepsy Market by Component
    • 7.3.4.5 Australia Tele-epilepsy Market
      • 7.3.4.5.1 Australia Tele-epilepsy Market by Patient
      • 7.3.4.5.2 Australia Tele-epilepsy Market by End Use
      • 7.3.4.5.3 Australia Tele-epilepsy Market by Component
    • 7.3.4.6 Malaysia Tele-epilepsy Market
      • 7.3.4.6.1 Malaysia Tele-epilepsy Market by Patient
      • 7.3.4.6.2 Malaysia Tele-epilepsy Market by End Use
      • 7.3.4.6.3 Malaysia Tele-epilepsy Market by Component
    • 7.3.4.7 Rest of Asia Pacific Tele-epilepsy Market
      • 7.3.4.7.1 Rest of Asia Pacific Tele-epilepsy Market by Patient
      • 7.3.4.7.2 Rest of Asia Pacific Tele-epilepsy Market by End Use
      • 7.3.4.7.3 Rest of Asia Pacific Tele-epilepsy Market by Component
• 7.4 LAMEA Tele-epilepsy Market
  • 7.4.1 LAMEA Tele-epilepsy Market by Patient
    • 7.4.1.1 LAMEA Adult Market by Country
    • 7.4.1.2 LAMEA Pediatric Market by Country
  • 7.4.2 LAMEA Tele-epilepsy Market by End Use
    • 7.4.2.1 LAMEA Healthcare Consumers Market by Country
    • 7.4.2.2 LAMEA Hospitals Providers Market by Country
    • 7.4.2.3 LAMEA Payers Market by Country
  • 7.4.3 LAMEA Tele-epilepsy Market by Component
    • 7.4.3.1 LAMEA Software Market by Country
    • 7.4.3.2 LAMEA Hardware Market by Country
    • 7.4.3.3 LAMEA Services Market by Country
  • 7.4.4 LAMEA Tele-epilepsy Market by Country
    • 7.4.4.1 Brazil Tele-epilepsy Market
      • 7.4.4.1.1 Brazil Tele-epilepsy Market by Patient
      • 7.4.4.1.2 Brazil Tele-epilepsy Market by End Use
      • 7.4.4.1.3 Brazil Tele-epilepsy Market by Component
    • 7.4.4.2 Argentina Tele-epilepsy Market
      • 7.4.4.2.1 Argentina Tele-epilepsy Market by Patient
      • 7.4.4.2.2 Argentina Tele-epilepsy Market by End Use
      • 7.4.4.2.3 Argentina Tele-epilepsy Market by Component
    • 7.4.4.3 UAE Tele-epilepsy Market
      • 7.4.4.3.1 UAE Tele-epilepsy Market by Patient
      • 7.4.4.3.2 UAE Tele-epilepsy Market by End Use
      • 7.4.4.3.3 UAE Tele-epilepsy Market by Component
    • 7.4.4.4 Saudi Arabia Tele-epilepsy Market
      • 7.4.4.4.1 Saudi Arabia Tele-epilepsy Market by Patient
      • 7.4.4.4.2 Saudi Arabia Tele-epilepsy Market by End Use
      • 7.4.4.4.3 Saudi Arabia Tele-epilepsy Market by Component
    • 7.4.4.5 South Africa Tele-epilepsy Market
      • 7.4.4.5.1 South Africa Tele-epilepsy Market by Patient
      • 7.4.4.5.2 South Africa Tele-epilepsy Market by End Use
      • 7.4.4.5.3 South Africa Tele-epilepsy Market by Component
    • 7.4.4.6 Nigeria Tele-epilepsy Market
      • 7.4.4.6.1 Nigeria Tele-epilepsy Market by Patient
      • 7.4.4.6.2 Nigeria Tele-epilepsy Market by End Use
      • 7.4.4.6.3 Nigeria Tele-epilepsy Market by Component
    • 7.4.4.7 Rest of LAMEA Tele-epilepsy Market
      • 7.4.4.7.1 Rest of LAMEA Tele-epilepsy Market by Patient
      • 7.4.4.7.2 Rest of LAMEA Tele-epilepsy Market by End Use
      • 7.4.4.7.3 Rest of LAMEA Tele-epilepsy Market by Component

Chapter 8. Company Profiles

• 8.1 Shimmer Research Ltd.
  • 8.1.1 Company Overview
• 8.2 EMOTIV, Inc.
  • 8.2.1 Company Overview
• 8.3 CortiCare, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Recent strategies and developments:
    • 8.3.2.1 Product Launches and Product Expansions:
• 8.4 SEVARO
  • 8.4.1 Company Overview
• 8.5 Tele Specialists
  • 8.5.1 Company Overview
• 8.6 Real Time Tele-Epilepsy Consultants
  • 8.6.1 Company Overview
• 8.7 ScienceSoft USA Corporation
  • 8.7.1 Company Overview
• 8.8 Zeto, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Recent strategies and developments:
    • 8.8.2.1 Product Launches and Product Expansions:
• 8.9 TeleEEG
  • 8.9.1 Company Overview
• 8.10. Epitel, Inc.
  • 8.10.1 Company Overview

Chapter 9. Winning Imperatives for Tele-epilepsy Market

관련자료